AT & S Austria Technologie & Systemtechnik AG (0O5C)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 139.40 |
|---|---|
| 52-week range | 25.00 – 242.00 |
| Return, 1 month / 3 months | −31.1% / −18.6% |
| Return, 1 year / 3 years | +390.8% / +499.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 32 |
| Volatility (1 year) | 83.1% |
| Worst drawdown (1 year) | -49.2% |
| Average daily value traded | 3.11M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AT & S Austria Technologie & Systemtechnik AG, known as AT&S, makes printed circuit boards and integrated circuit substrates for electronics manufacturers. Its products go into smartphones, computers, automotive electronics, industrial equipment and medical devices. The company serves customers in the electronics and technology industries from its base in Leoben, Austria, and operates manufacturing sites in Europe and Asia. It works with original equipment makers and electronics suppliers that need high-density interconnect and substrate technology for compact, high-performance devices.
The shares are listed on the London Exchange in UK under the code 0O5C, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AT & S Austria Technologie & Systemtechnik AG (0O5C) trades on the London Exchange in UK. It last closed at EUR 139.40 on 23 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,884 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 390.8% and over the last three months it fell 18.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 14.4% | ||
| From 52-week high | -40.8% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -18.6% | ||
| 6-month return | 56.5% | ||
| 12-month return, skipping the last month | 612.9% | ||
| Stability (higher is calmer) | 15 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 83.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.2% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.11M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −18.9% |
|---|---|
| 1 month | −31.1% |
| 3 months | −18.6% |
| 6 months | +56.5% |
| 1 year | +390.8% |
| 3 years | +499.3% |
| 5 years | +326.8% |
Signals
| 50-day / 200-day average | 175.99 / 121.88 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 28.04 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Jul 2023 | EUR 0.4000 |
| 26 Jul 2022 | EUR 0.1200 |
| 27 Jul 2021 | EUR 0.3900 |
| 28 Jul 2020 | EUR 0.2500 |
| 23 Jul 2019 | EUR 0.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.